Flic ingn 6.3 ef11/2/2022 ![]() ![]() The consensus estimate has shifted -33.64% due to these changes.Īt this time, Inogen has an average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. It turns out, estimates revision have trended downward during the past month. How Have Estimates Been Moving Since Then? Guidanceĭue to the uncertainty around the impact and scope of the COVID-19 pandemic on its business, the company has not issued full-year 2021 guidance. The company exited the fourth quarter with cash and cash equivalents of $211.9 million, compared with $213.9 million at the end of the third quarter. Loss from operations in the quarter was $5.5 million wider than the year-ago quarter’s loss of $5.3 million. Total operating costs were $39.6 million, up 0.9%. Gross margin came in at 46%, up a 310 basis points (bps). In the fourth quarter, gross profit was $34.1 million, up 0.4% year over year. Sales declined due to the impact of the COVID-19 pandemic on consumer travel and mobility, lower consumer confidence, and around 6% decline in average inside sales representative headcount and higher focus of its time on new rental setups. Per management, the decline was mainly led by resurgence of COVID-19 cases during the fourth quarter, leading to additional lockdowns in many European countries, and lowering of operating capacity of certain European respiratory assessment centers.ĭirect-to-consumer revenues fell 25.2% year over year to $26.8 million in the quarter. Internationally, this segment reported revenues of $13.6 million, down 20.4% year over year and 23.8% at constant currency. FLIC INGN 6.3 EF PORTABLEPer management, unfulfilled orders in fourth-quarter 2019 and higher demand for portable oxygen concentrators (“POCs”) contributed to the upside. Revenues by Region & Categoryīusiness-to-business revenues in the United States amounted to $24.2 million, up 17.9% on a year-over-year basis. Sales revenues were $64.6 million, down 12%. ![]() Rental revenues grossed $9.4 million, up 71.7% from the year-ago period. The figure surpassed the consensus mark by 1.6%. However, the top line declined 6.3% on a year-over-year basis primarily due to the impact of the COVID-19 pandemic.įor the full-year 2020, the company reported $308.5 million, down 14.8% from 2019. ![]() Revenues of this company amounted to $73.9 million, which beat the Zacks Consensus Estimate by 6.9%. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |